Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Notes have priced
Inv. presentation
LIGAND PHARMACEUTICALS INC (LGND) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Quarterly results
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Ligand Reports Second Quarter 2023 Financial Results Conference Call Begins at 4:30 p.m. Eastern Time Today"
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/16/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
Docs: "Ligand Reports First Quarter 2023 Financial Results 2023 Financial Guidance Raised Conference Call Begins at 4:30 p.m. Eastern Time Today"
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/13/2023 8-K Other Events  Interactive Data
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
Docs: "Ligand Reports Fourth Quarter and Full Year 2022 Financial Results 2023 Financial Guidance Raised Conference Call Begins at 4:30 p.m. Eastern Time Today"
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13D/A LIGAND PHARMACEUTICALS INC reports a 7.9% stake in Viking Therapeutics, Inc.
02/09/2023 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 0.8% stake in Ligand Pharmaceuticals Incorporated
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/14/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "Ligand Reports Third Quarter 2022 Financial Results"
11/04/2022 8-K Quarterly results
10/03/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/03/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off"
09/30/2022 8-K Quarterly results
09/30/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
08/24/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/10/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
08/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/29/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy